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ABSTRACT
Summary: We describe a tool, called ACE-it (Array CGH Expression
integration tool). ACE-it links the chromosomal position of the gene
dosage measured by array CGH to the genes measured by the
expression array. ACE-it uses this link to statistically test whether
gene dosage affects RNA expression.
Availability:ACE-it is freely available at http://ibivu.cs.vu.nl/programs/
acewww/
Contact: b.ylstra@vumc.nl
Supplementary Information: Programs, the manual and supple-
mentary information are available on the website.
Gene dosage, among other factors, affects gene expression in
tumors (Albertson et al., 2000; Pollack et al., 2002), and can be
measured on a genome-wide basis at high resolution by array com-
parative genomic hybridization (array CGH) (Pinkel and Albertson,
2005). Except for visualization implementations (Pollack et al.,
2002; Autio et al., 2003), and calculation of correlations without
formal inference (Nigro et al., 2005), sophisticated techniques for
the integration of array CGH with expression array data are limited.
A statistical tool for the detection of genes whose expression is
affected by gene dosage within a series of samples is currently
not available. ACE-it tests whether on a particular chromosomal
location the RNA expression ratios are affected by the gene
dosage. The relation with gene dosage is tested by ACE-it for
each gene on the expression array. For this purpose gene dosage
is divided into three categories: loss, normal or gain, defined by
means of a user chosen cut-off for smoothed data (Olshen et al.,
2004; Jong et al., 2004). Subsequently, the chromosomal positions
are divided into two groups: positions at which the samples have
either normal and gain, or normal and loss. The grouping disregards
positions at which all the samples fall into one category, have a
balanced distribution over the categories, or have no normals. The
restriction into these two groups of chromosomal positions is biolo-
gically motivated by the assumption that for a given chromosomal
location either oncogenes or tumor suppressor genes drive the
chromosomal gain or loss (Albertson et al., 2000; Pinkel and
Albertson, 2005). ACE-it allows a user-defined cut-off for conta-
minating samples within the groupings.
Thus, normalized expression ratios for a particular gene are
compared between the two categories within a group. ACE-it
assumes that expression increases with increased gene dosage.
This assumption leads to the null-hypothesis: (1) the median
expression in samples with a gain is equal or smaller than that in
samples with normal gene dosage; or, (2) the median expression
in samples with a normal is equal or smaller than that in samples
with a loss. We use the one-sided Wilcoxon’s rank test to test this
null-hypothesis, and apply the Benjamini–Hochberg’s multiplicity
correction to the resulting P-values (Benjamini and Hochberg,
1995). Genes whose adjusted P-value is smaller than the user-
defined rejection level are considered differentially expressed
















Fig. 1. ACE-it box plot of HER-2/neu at 17q12. Y-axis expression and X-axis
gene dosage; normal, group 2; and gain, group 3. If this chromosomal position
is gained, the expression is significantly higher.
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One compounding problem when linking gene dosage and RNA
expression is that often the two arrays for expression and CGH
are performed on different platforms (Ylstra et al., 2006). As a
consequence, the arrays can have different elements spotted such
that amount and chromosomal position of the ratios measured do not
overlap. We solved this by imputing segmented ratios for each
chromosomal position not covered by the arrayed elements, such
that any given position on the chromosome gets assigned the
smoothed array CGH value of the closest physical point of meas-
urement. If expression and CGH array are performed on the same
platform this feature may be disenabled.
ACE-it has been developed for the statistical software package R
(http://www.r-project.org/) and a graphical user interface (GUI)
for windows is provided. ACE-it was tested using array expression
and array CGH datasets from various institutes and platforms,
including a breast tumor series (Pollack et al., 2002). This yielded
several genes whose expression is significantly affected by gene
dosage, including HER-2/neu (c-erbB-2) which is amplified in
20–30% of breast cancer cases (Fig. 1).
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